Navigation Links
China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
Date:9/19/2008

SHANGHAI, China, Sept. 19 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) (''China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, announced today that at its 2008 Annual General Meeting of Shareholders (the ''AGM''), stockholders re-elected all of the Company's nominees to the Board of Directors.

At the meeting, held September 12, 2008, shareholders approved the re-election of Mr. Jinan Song, Dr. Ji Wei Chin, Dr. Wen Min Du and Mr. Simon Yick as members of the Company's Board of Directors. Shareholders also ratified the appointment of BDO McCabe Lo Limited as the Company's independent auditors for the fiscal year ending March 31, 2008.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company''), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the ''Shining'' brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., OMAHA, Neb., Nov. 5 T... announced financial results for the quarter ended...ts are presented in the tables that follow. ,, ...net loss of $366,000 or $0.01 per share for the th...499,000 or $0.01 per share for the third quarter o...
(Date:11/5/2009)..., FREMONT, Calif., Nov. 5 /PRNewswire-FirstCall/ ...WGBS), a leading developer of state-of-the-art gen...opher Sears, Ph.D. has joined the company,s Scient...on designing and commercializing novel molecular d...ions, and on the development of computational biol...
(Date:11/5/2009)... Brooke Sanders brings a new...ne, CA (PRWEB) November 5, 2009 -- Professional Re... reprographics company is pleased to present Brook... as their graphics/PR specialist. The addition of ...sistent growth within Professional Reprographics.,...
(Date:11/4/2009)..., ,, ROCKVILLE, Md., Nov. 4 /PRNewswire/ -... company focused on next-generation antibody drug ...10 million in Series A funding from New Enterprise...ure capital firms. The capital will be used to cre...that address two or more biological targets with a...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...y insiders knowingly misrepresented the .... 18 Hagens Berman Sobol Shapiro filed a,proposed...cs Corporation,(OTC Bulletin Board: CCYG) sharehol...esented the company and chief executive officer Ga...be traded at artificially,inflated prices., The l...
... and Company,strongly objects to implications in a...e company has suppressed results of negative clini...le in The New England Journal of,Medicine (NEJM), ... how the,industry purportedly suppresses negative ... inaccurate when it comes to Prozac -- the NEJM ar...
...utics Corporation today,announced the appointment ...Alliance Management. In this role, Ms. Perrow will...opment strategy and program execution through,prod...l also serve as a,member of Alba,s executive manag...nnounce that Ms. Perrow is joining Alba in,this cr...
Other Biology Technology:Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 2Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management 2
(Date:11/4/2009)...D, Calif., Oct. 23 GenVault Corpor... management for genomic discovery, medicine and id...h.D., GenVault,s President and CEO, will be presen...e on October 26th and 27th in La Jolla, CA. ,, ...n overview of the company together with recent cus...
(Date:11/4/2009)...K, Oct. 27 Global Rainmakers, Inc....anced R&D laboratory, today announced that the...ared to actively commercialize its suite of techno... security offerings. ,, During the past four ye...lars to develop and deploy a series of core--but e...
(Date:11/4/2009)...D, Calif., Nov. 4 GenVault Corpora...rody, M.D., Ph.D., has joined its Board of Directo...r of the Salk Institute, is an acclaimed physician...g the Salk Institute, Dr. Brody served as presiden... of the National Academy of Engineering and the In...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Martin Hensen head of e strategies UCB Germany 3A Making e marketing more than just an add on 9458 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 3Five Questions About Protopic 28tacrolimus 29 Ointment 13332 4Synthetic biology opportunities and risks 53488 1Synthetic biology opportunities and risks 53488 2Synthetic biology opportunities and risks 53488 3
...ed to exploring ways to broaden the use of clean, ...y 1 at Stanford University. , Energy Crossroads, ...ms to reduce society,s dependence on fossil fuels,...ion: Sparking Global Change." , Cathy Zoi, chief ...ection, a nonprofit organization founded by former...
...gist Stephan B. Poulter demonstrates in THE MOTHER... YOUR LIFE (Prometheus Books, $18.95) that most of...ted by our mothers or its far-reaching impact on o... the foundation from which our emotional developme...ve through adulthood. No other relationship in ou...
...ollaborative effort, researchers from Boston Unive...at deletions or mutations within the TFAP2A gene (... distinctive clefting disorder Branchio-Oculo-Faci...erized by specific skin anomalies involving the ne...l facial appearance, and frequently cleft lip and ...
Other Biology News:How your mother's emotional legacy impacts your life 2
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Immunoblot Blocking Reagent from Upstate
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Amido Black 10B, CI 20470 from Research Organics, Inc.
Biology Products: